194 related articles for article (PubMed ID: 32561125)
1. Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Dilley J; Burnell M; Gentry-Maharaj A; Ryan A; Neophytou C; Apostolidou S; Karpinskyj C; Kalsi J; Mould T; Woolas R; Singh N; Widschwendter M; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
Gynecol Oncol; 2020 Aug; 158(2):316-322. PubMed ID: 32561125
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Dilley J; Gentry-Maharaj A; Ryan A; Burnell M; Manchanda R; Kalsi J; Singh N; Woolas R; Sharma A; Williamson K; Mould T; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
Gynecol Oncol; 2023 Dec; 179():123-130. PubMed ID: 37980767
[TBL] [Abstract][Full Text] [Related]
3. Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Moss HA; Berchuck A; Neely ML; Myers ER; Havrilesky LJ
JAMA Oncol; 2018 Feb; 4(2):190-195. PubMed ID: 29222541
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Singh N; Ryan A; Karpinskyj C; Carlino G; Taylor J; Massingham SK; Raikou M; Kalsi JK; Woolas R; Manchanda R; Arora R; Casey L; Dawnay A; Dobbs S; Leeson S; Mould T; Seif MW; Sharma A; Williamson K; Liu Y; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Jacobs IJ; Parmar M
Lancet; 2021 Jun; 397(10290):2182-2193. PubMed ID: 33991479
[TBL] [Abstract][Full Text] [Related]
5. Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study.
Sharma A; Gentry-Maharaj A; Burnell M; Fourkala EO; Campbell S; Amso N; Seif MW; Ryan A; Parmar M; Jacobs I; Menon U;
BJOG; 2012 Jan; 119(2):207-19. PubMed ID: 21762355
[TBL] [Abstract][Full Text] [Related]
6. Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS.
Taylor JA; Burnell M; Ryan A; Karpinskyj C; Kalsi JK; Taylor H; Apostolidou S; Sharma A; Manchanda R; Woolas R; Campbell S; Parmar M; Singh N; Jacobs IJ; Menon U; Gentry-Maharaj A
BJOG; 2022 Jan; 129(1):110-118. PubMed ID: 34555263
[TBL] [Abstract][Full Text] [Related]
7. Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.
Lim A; Mesher D; Gentry-Maharaj A; Balogun N; Widschwendter M; Jacobs I; Sasieni P; Menon U
BJOG; 2016 May; 123(6):1012-20. PubMed ID: 26032603
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Jacobs IJ; Menon U; Ryan A; Gentry-Maharaj A; Burnell M; Kalsi JK; Amso NN; Apostolidou S; Benjamin E; Cruickshank D; Crump DN; Davies SK; Dawnay A; Dobbs S; Fletcher G; Ford J; Godfrey K; Gunu R; Habib M; Hallett R; Herod J; Jenkins H; Karpinskyj C; Leeson S; Lewis SJ; Liston WR; Lopes A; Mould T; Murdoch J; Oram D; Rabideau DJ; Reynolds K; Scott I; Seif MW; Sharma A; Singh N; Taylor J; Warburton F; Widschwendter M; Williamson K; Woolas R; Fallowfield L; McGuire AJ; Campbell S; Parmar M; Skates SJ
Lancet; 2016 Mar; 387(10022):945-956. PubMed ID: 26707054
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.
Lim AW; Mesher D; Gentry-Maharaj A; Balogun N; Jacobs I; Menon U; Sasieni P
J Natl Cancer Inst; 2012 Jan; 104(2):114-24. PubMed ID: 22247022
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Thomas DS; Gentry-Maharaj A; Ryan A; Fourkala EO; Apostolidou S; Burnell M; Alderton W; Barnes J; Timms JF; Menon U
Cancer Epidemiol; 2019 Feb; 58():167-174. PubMed ID: 30616086
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Menon U; Gentry-Maharaj A; Hallett R; Ryan A; Burnell M; Sharma A; Lewis S; Davies S; Philpott S; Lopes A; Godfrey K; Oram D; Herod J; Williamson K; Seif MW; Scott I; Mould T; Woolas R; Murdoch J; Dobbs S; Amso NN; Leeson S; Cruickshank D; McGuire A; Campbell S; Fallowfield L; Singh N; Dawnay A; Skates SJ; Parmar M; Jacobs I
Lancet Oncol; 2009 Apr; 10(4):327-40. PubMed ID: 19282241
[TBL] [Abstract][Full Text] [Related]
12. Development of an ovarian cancer symptom index: possibilities for earlier detection.
Goff BA; Mandel LS; Drescher CW; Urban N; Gough S; Schurman KM; Patras J; Mahony BS; Andersen MR
Cancer; 2007 Jan; 109(2):221-7. PubMed ID: 17154394
[TBL] [Abstract][Full Text] [Related]
13. Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gentry-Maharaj A; Glazer C; Burnell M; Ryan A; Berry H; Kalsi J; Woolas R; Skates SJ; Campbell S; Parmar M; Jacobs I; Menon U
BMJ Open; 2017 Mar; 7(3):e011822. PubMed ID: 28264823
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group.
Altman AD; Lambert P; Love AJ; Turner D; Lotocki R; Dean E; Popowich S; Nachtigal MW
Int J Gynecol Cancer; 2017 Oct; 27(8):1637-1644. PubMed ID: 28704327
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of symptoms for early detection of ovarian cancer.
Rossing MA; Wicklund KG; Cushing-Haugen KL; Weiss NS
J Natl Cancer Inst; 2010 Feb; 102(4):222-9. PubMed ID: 20110551
[TBL] [Abstract][Full Text] [Related]
17. Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial.
Narod SA; Sopik V; Giannakeas V
Gynecol Oncol; 2016 May; 141(2):191-194. PubMed ID: 26915499
[No Abstract] [Full Text] [Related]
18. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS).
Sharma A; Apostolidou S; Burnell M; Campbell S; Habib M; Gentry-Maharaj A; Amso N; Seif MW; Fletcher G; Singh N; Benjamin E; Brunell C; Turner G; Rangar R; Godfrey K; Oram D; Herod J; Williamson K; Jenkins H; Mould T; Woolas R; Murdoch J; Dobbs S; Leeson S; Cruickshank D; Fourkala EO; Ryan A; Parmar M; Jacobs I; Menon U
Ultrasound Obstet Gynecol; 2012 Sep; 40(3):338-44. PubMed ID: 22911637
[TBL] [Abstract][Full Text] [Related]
19. Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records.
Lim AW; Mesher D; Sasieni P
BMC Fam Pract; 2014 Dec; 15():200. PubMed ID: 25496012
[TBL] [Abstract][Full Text] [Related]
20. Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar.
Kalsi JK; Ryan A; Gentry-Maharaj A; Margolin-Crump D; Singh N; Burnell M; Benjamin E; Apostolidou S; Habib M; Massingham S; Karpinskyj C; Woolas R; Widschwendter M; Fallowfield L; Campbell S; Skates S; McGuire A; Parmar M; Jacobs I; Menon U
Trials; 2021 Jan; 22(1):88. PubMed ID: 33494753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
